Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

USSA cross country 2008
2008-10-16

The student cross country championships of 2008 took place on the 29 and 30 September 2008 at the University of Kwazulu Natal.

‘n Total of 109 athletes took part. The Kovsies men`s team was Boy Soke, Johan Cronje, Michael Tlhoro, Dirk Gouws, Ben Smit and Antonie Peens. The womens team was represented by Este de Jager, Abongile Lerotholi, Thandi Malindi, Rone Reynecke en Maryna Swanepoel.

The women’s team took the honours by winning the team competition in the 4km race. They finished as follows: De Jager 3rd, Lerotholi 5th, Malindi 6th, Reynecke 7th and Swanepoel 16th.

The men’s team also did well under circumstances – Our number 2 and 3 runners were injured and Antonie Peens, our number 5, was diagnosed with measles on the morning of the race. They finished 3rd in the men`s 4km race. However the men can kept their heads high. They finished as follow: Soke 2nd, Cronje 12th, Tlhoro 17th, Gouws 29th and Smit 39 th.

In the road relay race our womens team again did us proud by winning the race by a huge margin. Our team was Thandi Malindi, Abongile Lerotholi and Este de Jager.

The men`s team perform well under difficult circumstances by finishing 4th.  The team was Dirk Gouws, Johan Cronje, Michael Tlhoro en Boy Soke.

Este de Jager

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept